257 related articles for article (PubMed ID: 23085436)
1. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
Irwin N; Montgomery IA; Moffett RC; Flatt PR
Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal mice.
Irwin N; Frizelle P; O'Harte FP; Flatt PR
J Endocrinol; 2013 Jan; 216(1):53-9. PubMed ID: 23055535
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of (pGlu-Gln)-CCK-8 on energy intake and metabolism in high fat fed mice are associated with alterations of hypothalamic gene expression.
Montgomery IA; Irwin N; Flatt PR
Horm Metab Res; 2013 Jun; 45(6):471-3. PubMed ID: 23315994
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes.
Irwin N; Frizelle P; Montgomery IA; Moffett RC; O'Harte FPM; Flatt PR
Diabetologia; 2012 Oct; 55(10):2747-2758. PubMed ID: 22814764
[TBL] [Abstract][Full Text] [Related]
5. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
Irwin N; Hunter K; Montgomery IA; Flatt PR
Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
[TBL] [Abstract][Full Text] [Related]
6. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
Irwin N; Pathak V; Flatt PR
Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
[TBL] [Abstract][Full Text] [Related]
7. (pGlu-Gln)-CCK-8[mPEG]: a novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetes.
Irwin N; Frizelle P; O'Harte FP; Flatt PR
Biochim Biophys Acta; 2013 Aug; 1830(8):4009-16. PubMed ID: 23583730
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes.
Irwin N; Montgomery IA; O'Harte FP; Frizelle P; Flatt PR
Int J Obes (Lond); 2013 Aug; 37(8):1058-63. PubMed ID: 23164696
[TBL] [Abstract][Full Text] [Related]
9. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
O'Harte FP; Franklin ZJ; Irwin N
Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice.
Irwin N; Montgomery IA; Flatt PR
Diabetologia; 2013 Jun; 56(6):1425-35. PubMed ID: 23462797
[TBL] [Abstract][Full Text] [Related]
12. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
13. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
[TBL] [Abstract][Full Text] [Related]
14. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
15. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
[TBL] [Abstract][Full Text] [Related]
16. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.
Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB
Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657
[TBL] [Abstract][Full Text] [Related]
18. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
[TBL] [Abstract][Full Text] [Related]
19. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
Irwin N; McClean PL; Flatt PR
J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
